Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteria

Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteria

Bibliographic Details
Main Authors:	Jan Heyckendorf, Stephen H. Gillespie, Morten Ruhwald
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S235239642030493X

Similar Items

Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis
by: Christina Jensen, et al.
Published: (2017-06-01)

Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure
by: Atiqa Ambreen, et al.
Published: (2019-10-01)

A simple, quantitative assay for the detection of viable but non-culturable (VBNC) bacteria
by: Ignacio Servando Arvizu, et al.
Published: (2021-09-01)

Boosting effect of IL-7 in interferon gamma release assays to diagnose Mycobacterium tuberculosis infection.
by: Hellen Hiza, et al.
Published: (2018-01-01)

Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
by: Kidola Jeremiah, et al.
Published: (2021-01-01)

A.C. electrokinetic bioassays : development of electrorotation assay for detection of viable and non-viable bacteria and macromolecules
by: Mitchell, Clare Elizabeth
Published: (2001)

Using diphenyleneiodonium to induce a viable but non-culturable phenotype in Mycobacterium tuberculosis and its metabolomics analysis.
by: Amar Yeware, et al.
Published: (2019-01-01)

Mycobacterium Growth Inhibition Assay of Human Alveolar Macrophages as a Correlate of Immune Protection Following Mycobacterium bovis Bacille Calmette–Guérin Vaccination
by: Juliane Radloff, et al.
Published: (2018-07-01)

Biosynthesis of Galactan in <i>Mycobacterium tuberculosis</i> as a Viable TB Drug Target?
by: Zuzana Konyariková, et al.
Published: (2020-01-01)

Diagnostic Significance of Mycobacterium tuberculosis T-cell Assays for Active Tuberculosis
by: Wei-Xia Xuan, et al.
Published: (2017-01-01)

Routine Culture–Resistant Mycobacterium tuberculosis Rescue and Shell-Vial Assay, France
by: Mustapha Fellag, et al.
Published: (2019-11-01)

Detection and Quantification of Mycobacterium tuberculosis in the Sputum of Culture-Negative HIV-infected Pulmonary Tuberculosis Suspects: A Proof-of-Concept Study.
by: Guillermo Madico, et al.
Published: (2016-01-01)

A new method of detecting and enumerating viable bacteria.
by: Light, Marilyn H. S., 1942-
Published: (1967)

Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium tuberculosis Infection?
by: Michael D. Stutz, et al.
Published: (2018-05-01)

Efficacy and role of Xpert® Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis
by: Benedict Paul Samuel, et al.
Published: (2018-01-01)

Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots.
by: Thomas Blauenfeldt, et al.
Published: (2014-01-01)

Use of immunochromatographic assay for rapid identification of Mycobacterium tuberculosis complex from liquid culture
by: Anika Považan, et al.
Published: (2012-02-01)

Current Perspectives on Viable but Non-Culturable (VBNC) Pathogenic Bacteria
by: Thandavarayan eRamamurthy, et al.
Published: (2014-07-01)

An investigation into the molecular basis of the viable but non-culturable response in bacteria
by: Barrett, Tanya
Published: (1998)

Development of isothermal amplification assay for the detection of Mycobacterium tuberculosis
by: M.S. Nur Eyuni, et al.
Published: (2020-12-01)

An IMS/ATP Assay for the Detection of Mycobacterium tuberculosis in Urine
by: Dawn M. Hunter, et al.
Published: (2012-01-01)

MPT64 assays for the rapid detection of Mycobacterium tuberculosis
by: Xun-Jie Cao, et al.
Published: (2021-04-01)

Detection of Viable Bacteria during Sludge Ozonation by the Combination of ATP Assay with PMA-Miseq Sequencing
by: Shaonan Tian, et al.
Published: (2017-02-01)

Introduce of Viable But Nonculturable Bacteria
by: Mehdi Hassanshahian, et al.
Published: (2008-03-01)

Differential Effect of Viable Versus Necrotic Neutrophils on Mycobacterium tuberculosis Growth and Cytokine Induction in Whole Blood
by: David M. Lowe, et al.
Published: (2018-04-01)

Molecular diagnosis of tuberculosis with emphasis on Xpert Mycobacterium tuberculosis assay – Clinical review
by: Gajanan S Gaude, et al.
Published: (2020-01-01)

XtracTB Assay, a Mycobacterium tuberculosis molecular screening test with sensitivity approaching culture
by: Jennifer L. Reed, et al.
Published: (2017-06-01)

Dual color fluorescence in situ hybridization (FISH) assays for detecting Mycobacterium tuberculosis and Mycobacterium avium complexes and related pathogens in cultures.
by: Jyotsna Shah, et al.
Published: (2017-01-01)

Evolution and diversity of clonal bacteria: the paradigm of Mycobacterium tuberculosis.
by: Tiago Dos Vultos, et al.
Published: (2008-01-01)

Time to culture positivity and sputum smear microscopy during tuberculosis therapy.
by: Ioana D Olaru, et al.
Published: (2014-01-01)

Pyrosequencing assay for rapid identification of <it>Mycobacterium tuberculosis </it>complex species
by: Boukadida Jalel, et al.
Published: (2011-10-01)

Validation of an immunochromatographic assay kit for the identification of the Mycobacterium tuberculosis complex
by: Al-Habib Omar Said Toihir, et al.
Published: (2011-09-01)

An improved method for detection of pyrazinamide resistance in Mycobacterium tuberculosis
by: Amani Alnimr, et al.
Published: (2012-01-01)

Utility of GeneXpert Mycobacterium tuberculosis/rifampicin assay in smear-negative pulmonary tuberculosis
by: Javeriya Mohammadi, et al.
Published: (2021-01-01)

Learning from COVID-19 to reimagine tuberculosis diagnosis
by: Morten Ruhwald, et al.
Published: (2021-05-01)

Comparison of Culture, Real-Time DNA Amplification Assay and Ehrlich-Ziehl-Neelsen for Detection of Mycobacterium tuberculosis
by: Adil Karadağ, et al.
Published: (2013-03-01)

IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with <it>M. tuberculosis </it>in a whole blood based T-cell assay
by: Rabna Paulo, et al.
Published: (2009-02-01)

Investigating the physiology of viable but non-culturable bacteria by microfluidics and time-lapse microscopy
by: Rosemary A. Bamford, et al.
Published: (2017-12-01)

Determination of the activity of standard anti-tuberculosis drugs against intramacrophage Mycobacterium tuberculosis, in vitro: MGIT 960 as a viable alternative for BACTEC 460
by: Sarbjit Singh Jhamb, et al.
Published: (2014-05-01)

Detection of rifampin-resistant genotypes in Mycobacterium tuberculosis by reverse hybridization assay
by: Raquel de A Maschmann, et al.
Published: (2011-03-01)